YU47699A - Quinoline-2-carboxylic acid derivative and its use as excitatory amino acids antagonists - Google Patents
Quinoline-2-carboxylic acid derivative and its use as excitatory amino acids antagonistsInfo
- Publication number
- YU47699A YU47699A YU47699A YU47699A YU47699A YU 47699 A YU47699 A YU 47699A YU 47699 A YU47699 A YU 47699A YU 47699 A YU47699 A YU 47699A YU 47699 A YU47699 A YU 47699A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- carboxylic acid
- amino acids
- quinoline
- antagonists
- excitatory amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The (+) enantiomer of E 4-(4-Acetylamino-phenylcarbamoylmethylene)-5,7-dichloro-1,2,3,4-tetrahydro quinoline 2-carboxylic acid and salt thereof which are antagonist of excitatory amino acids, to processes for their preparation, to pharmaceutical compositions containing them, and to their use in medicine.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9706294.7A GB9706294D0 (en) | 1997-03-26 | 1997-03-26 | Heterocyclic compound |
Publications (1)
Publication Number | Publication Date |
---|---|
YU47699A true YU47699A (en) | 2001-12-26 |
Family
ID=10809909
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU47699A YU47699A (en) | 1997-03-26 | 1998-03-24 | Quinoline-2-carboxylic acid derivative and its use as excitatory amino acids antagonists |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP0971896A1 (en) |
JP (1) | JP2001518901A (en) |
KR (1) | KR20010005567A (en) |
CN (1) | CN1257482A (en) |
AP (1) | AP9901659A0 (en) |
AU (1) | AU731394B2 (en) |
BR (1) | BR9808424A (en) |
CA (1) | CA2284710A1 (en) |
EA (1) | EA199900755A1 (en) |
GB (1) | GB9706294D0 (en) |
HU (1) | HUP0001661A3 (en) |
ID (1) | ID24306A (en) |
IL (1) | IL131919A0 (en) |
IS (1) | IS5186A (en) |
NO (1) | NO994679L (en) |
NZ (1) | NZ337793A (en) |
PL (1) | PL335865A1 (en) |
TR (1) | TR199902315T2 (en) |
WO (1) | WO1998042673A1 (en) |
YU (1) | YU47699A (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9917822D0 (en) * | 1999-07-29 | 1999-09-29 | Imperial College | Nmda antagonist |
DE10132725A1 (en) | 2001-07-05 | 2006-08-03 | Grünenthal GmbH | Substituted γ-lactone compounds |
DE10137487A1 (en) * | 2001-08-03 | 2003-03-27 | Gruenenthal Gmbh | Substituted 5,6,6a, 11b-tetrahydro-7-oxa-6-aza-benzo [c] fluorene-6-carboxylic acid derivatives |
DE10306202A1 (en) | 2003-02-13 | 2004-08-26 | Grünenthal GmbH | 2-(hetero)aryl-2-(N-((hetero)aryl)-amino)-acetic acid derivatives useful e.g. for treating anxiety, inflammation, allergy, depression, diarrhea or especially pain is NMDA antagonist |
JP4360891B2 (en) | 2003-12-09 | 2009-11-11 | アルパイン株式会社 | Electronic device having broadcast receiving function and display method of electronic program guide in the device |
KR101136183B1 (en) | 2005-07-22 | 2012-04-17 | 모찌다 세이야쿠 가부시끼가이샤 | Novel heterocyclidene acetamide derivative |
RU2451014C2 (en) * | 2005-07-22 | 2012-05-20 | Мотида Фармасьютикал Ко., Лтд. | Novel heterocyclidene acetamide derivative |
US9737531B2 (en) | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
BR112019026449A2 (en) | 2017-06-12 | 2020-08-11 | Glytech Llc. | composition and method for treating depression and psychosis in humans |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69029668T2 (en) * | 1989-03-08 | 1997-08-07 | Merck Sharp & Dohme | Tetrahydroquinoline derivatives, useful for neurodegenerative diseases |
DE69622731T2 (en) * | 1995-09-29 | 2003-02-20 | Glaxosmithkline S.P.A., Verona | TETRAHYDROCHINOLINE AS NMDA ANTAGONISTS |
GB9617305D0 (en) * | 1996-08-17 | 1996-09-25 | Glaxo Wellcome Spa | Heterocyclic compounds |
-
1997
- 1997-03-26 GB GBGB9706294.7A patent/GB9706294D0/en active Pending
-
1998
- 1998-03-24 AP APAP/P/1999/001659A patent/AP9901659A0/en unknown
- 1998-03-24 YU YU47699A patent/YU47699A/en unknown
- 1998-03-24 JP JP54323498A patent/JP2001518901A/en active Pending
- 1998-03-24 HU HU0001661A patent/HUP0001661A3/en unknown
- 1998-03-24 PL PL98335865A patent/PL335865A1/en unknown
- 1998-03-24 KR KR1019997008630A patent/KR20010005567A/en not_active Application Discontinuation
- 1998-03-24 EA EA199900755A patent/EA199900755A1/en unknown
- 1998-03-24 EP EP98919133A patent/EP0971896A1/en not_active Withdrawn
- 1998-03-24 CN CN98805302A patent/CN1257482A/en active Pending
- 1998-03-24 TR TR1999/02315T patent/TR199902315T2/en unknown
- 1998-03-24 IL IL13191998A patent/IL131919A0/en unknown
- 1998-03-24 BR BR9808424-0A patent/BR9808424A/en not_active IP Right Cessation
- 1998-03-24 ID IDW991108A patent/ID24306A/en unknown
- 1998-03-24 CA CA002284710A patent/CA2284710A1/en not_active Abandoned
- 1998-03-24 AU AU72094/98A patent/AU731394B2/en not_active Ceased
- 1998-03-24 NZ NZ337793A patent/NZ337793A/en unknown
- 1998-03-24 WO PCT/EP1998/001700 patent/WO1998042673A1/en not_active Application Discontinuation
-
1999
- 1999-09-17 IS IS5186A patent/IS5186A/en unknown
- 1999-09-24 NO NO994679A patent/NO994679L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AP9901659A0 (en) | 1999-09-30 |
TR199902315T2 (en) | 2000-05-22 |
GB9706294D0 (en) | 1997-05-14 |
HUP0001661A2 (en) | 2000-09-28 |
AU731394B2 (en) | 2001-03-29 |
PL335865A1 (en) | 2000-05-22 |
HUP0001661A3 (en) | 2001-12-28 |
EP0971896A1 (en) | 2000-01-19 |
ID24306A (en) | 2000-07-13 |
EA199900755A1 (en) | 2000-08-28 |
BR9808424A (en) | 2000-05-23 |
WO1998042673A1 (en) | 1998-10-01 |
IL131919A0 (en) | 2001-03-19 |
IS5186A (en) | 1999-09-17 |
AU7209498A (en) | 1998-10-20 |
CA2284710A1 (en) | 1998-10-01 |
NO994679L (en) | 1999-11-24 |
NO994679D0 (en) | 1999-09-24 |
JP2001518901A (en) | 2001-10-16 |
NZ337793A (en) | 2001-02-23 |
KR20010005567A (en) | 2001-01-15 |
CN1257482A (en) | 2000-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003020698A3 (en) | Protein tyrosine kinase inhibitors | |
BR0315547A (en) | Quinoline derivatives as crth2 antagonists | |
DE60037020D1 (en) | Anilinochinazoline als protein-tyrosin-kinasehemmer | |
TR200002015T2 (en) | Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors. | |
HUP0004490A3 (en) | Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threoning kinase inhibitors and pharmaceutical compositions containing them | |
CA2473991A1 (en) | Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor | |
MY115638A (en) | N-substituted heterocyclic derivatives, their preparation and pharmaceutical compositions containing them | |
IL90435A0 (en) | 4-(quinolin-2-yl-methoxy)phenylacetic acid derivatives,their preparation and pharmaceutical compositions containing them | |
HUP0105133A3 (en) | Quinoline derivatives and quinazoline derivatives, pharmaceutical compositions containing them and their use | |
TR199801861T2 (en) | Pharmaceutically useful compositions. | |
EP1179533A3 (en) | Salt of naphthyridine carboxylic acid derivative | |
TR199900336T2 (en) | Tetrahydroquinoline derivatives as EAA antagonists. | |
MX9801987A (en) | Amino acid derivatives, the preparation and use thereof as endothelin antagonists. | |
YU47699A (en) | Quinoline-2-carboxylic acid derivative and its use as excitatory amino acids antagonists | |
TR199800531T1 (en) | Tetrahydroquinolines as NMDA antagonists. | |
HUP0301080A3 (en) | Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives, process for their preparation and pharmaceutical compositions containing them | |
CY1106105T1 (en) | MEGLUMINE SALT OF A SPECIFIC QUINOLINECARBOXYLIC ACID ACTIVE AT NMDA RECEPTORS | |
DE69922936D1 (en) | USE OF INDOL-2,3-DIONE-3-OXIM DERIVATIVES AS AMPA ANTAGONISTS | |
TR199901380A2 (en) | Di-ya da triazo-spiro$4.5] dean t�revleri | |
AU2002214223A1 (en) | Long-acting cytokine derivatives and pharmaceutical compositions comprising them | |
BG106329A (en) | Taste masking of oral quinolone liquid preparations using ion exchange resins | |
BG105618A (en) | Beta-amido and beta-sulphonamide derivatives of carboxylic acids, method for preparation and application as endothelin-receptor antagonists | |
IL160160A0 (en) | SUBSTITUTED 5,6,6a, 11b-TETRAHYDRO-7-OXA-5-AZA-BENZO[c]FLUORENE-6-CARBOXYLIC ACID DERIVATIVES SERVING AS NMDA ANTAGONISTS | |
BG108165A (en) | Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone | |
TR199802419T2 (en) | Brand New Pyridazine Compounds. |